Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
– Findings demonstrate significant reduction in pain and opioid consumption through 96 hours versus active comparator –
– Significantly greater proportion of opioid-free patients receiving EXPAREL –
Posted In: PCRX